Balancing Hope and Heart: An Umbrella Review of Cardiotoxicity in Immune Checkpoint Inhibitor Cancer Therapies
{{output}}
Background: Immune checkpoint inhibitors (ICIs) have significantly advanced cancer treatment, especially in improving survival rates for patients with various malignancies such as melanoma, non-small cell lung cancer (NSCLC), and... ...
